Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology to optimize drug...

̶ Results from Long-Term Safety Study and Data from Healthcare Resource Utilization Research Offer Insights into Treatment Experiences for People Living with Schizophrenia or Bipolar I Disorder...

In collaboration with leading cancer centers, research results to be presented from 41 studies across 19 solid tumor types demonstrating Caris' impact on precision medicine IRVING, Texas, May 14, 2024

BSV DevCon is inviting blockchain enthusiasts, professionals, entrepreneurs, and innovators for a day of insightful sessions, hands-on workshops, and networking opportunities. Set to take place on...

Expands its proprietary battery technology to provide new mobile EV charging options GILBERT, Ariz., May 14, 2024 /PRNewswire/ -- ZEVx™, Inc., a worldwide leader in mobile EV charging, today...